Abstract | BACKGROUND: The family of polypeptide N-acetylgalactosaminyl transferases is responsible for the altered O-linked glycosylation occurring during the development of various cancers and their progression via altering O- glycan biosynthesis. Our studies were designed to investigate the expression and prognostic values of GalNAc-T5 and improve the risk stratification in patients with gastric cancer. METHODS: Tissue samples from a training set and a validation set of patients with gastric adenocarcinoma from China were used for analyses. GalNAc-T5 expression was retrospectively analysed by immunohistochemistry. Results were assessed for association with clinicopathological parameters and overall survival by using Kaplan-Meier analysis. Prognostic values of GalNAc-T5 expression and clinical outcomes were evaluated by Cox regression analysis. A molecular prognostic stratification scheme incorporating GalNAc-T5 expression was determined by using receiver operating characteristic analysis. RESULTS:
GalNAc-T5 expression was markedly reduced in gastric cancer tissues compared with non-malignant gastric mucosa. Low intratumoral GalNAc-T5 density, which was associated with tumour cell differentiation, T classification, N classification, and TNM stage in the two independent sets, was an independent prognosticator for poor prognosis of gastric cancer patients. Applying the prognostic value of intratumoral GalNAc-T5 density to the conventional clinicopathologic TNM stage system showed a better prognostic value in patients with gastric cancer. CONCLUSIONS: Intratumoral GalNAc-T5 expression was recognised as an independent prognostic marker for the overall survival of gastric cancer patients. Detection of GalNAc-T5 expression in gastric cancer tissues might add some prognostic information for patients with this disease and lead to a more accurate classification under the TNM stage system.
|
Authors | H He, Z Shen, H Zhang, X Wang, Z Tang, J Xu, Y Sun |
Journal | British journal of cancer
(Br J Cancer)
Vol. 110
Issue 8
Pg. 2021-9
(Apr 15 2014)
ISSN: 1532-1827 [Electronic] England |
PMID | 24619076
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- N-Acetylgalactosaminyltransferases
- polypeptide N-acetylgalactosaminyltransferase
|
Topics |
- Aged
- Biomarkers, Tumor
(genetics)
- Disease-Free Survival
- Female
- Gene Expression Regulation, Neoplastic
- Glycosylation
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Molecular Targeted Therapy
- N-Acetylgalactosaminyltransferases
(genetics)
- Neoplasm Staging
- Prognosis
- Stomach Neoplasms
(drug therapy, genetics, pathology)
|